FGF23 and chronic kidney disease: This is the first prospective, crossover, randomized trial of patients with CKD to examine the safety of walnut consumption on the physiological levels of phosphorous, potassium, PTH, and FGF23, and to assess the short-term cardiovascular benefits of daily walnut consumption.